24 articles for A Srivastava
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
N-aryl-2-aminobenzimidazoles: novel, efficacious, antimalarial lead compounds.
Astrazeneca
Design, synthesis and molecular docking of substituted 3-hydrazinyl-3-oxo-propanamides as anti-tubercular agents.
Csir-Central Drug Research Institute
Lead optimization of isocytosine-derived xanthine oxidase inhibitors.
Piramal Healthcare
Isocytosine-based inhibitors of xanthine oxidase: design, synthesis, SAR, PK and in vivo efficacy in rat model of hyperuricemia.
Piramal Healthcare
Identification of novel isocytosine derivatives as xanthine oxidase inhibitors from a set of virtual screening hits.
Piramal Healthcare
Identification of novel parasitic cysteine protease inhibitors using virtual screening. 1. The ChemBridge database.
University of Mississippi
Identification of novel parasitic cysteine protease inhibitors by use of virtual screening. 2. The available chemical directory.
University of Mississippi
Discovery of a new class of HMG-CoA reductase inhibitor from Polyalthia longifolia as potential lipid lowering agent.
Central Drug Research Institute (Csir)
Creating an antibacterial with in vivo efficacy: synthesis and characterization of potent inhibitors of the bacterial cell division protein FtsZ with improved pharmaceutical properties.
Biota Europe
A prodomain peptide of Plasmodium falciparum cysteine protease (falcipain-2) inhibits malaria parasite development.
International Center For Genetic Engineering and Biotechnology
Mechanistic Investigation of Thiazole-Based Pyruvate Kinase M2 Inhibitor Causing Tumor Regression in Triple-Negative Breast Cancer.
National Institute of Pharmaceutical Education and Research-Ahmedabad (NIPER-A)
Optimization of 1,2,4-Triazole-Based p97 Inhibitors for the Treatment of Cancer.
University of Pittsburgh Chemical Diversity Center
Discovery of Potent and Selective Dual Leucine Zipper Kinase/Leucine Zipper-Bearing Kinase Inhibitors with Neuroprotective Properties in In Vitro and In Vivo Models of Amyotrophic Lateral Sclerosis.
Denali Therapeutics
Design and synthesis of potent, non-peptidic inhibitors of HPTPbeta.
Procter & Gamble Pharmaceuticals
Discovery of boronic acid-based potent activators of tumor pyruvate kinase M2 and development of gastroretentive nanoformulation for oral dosing.
National Institute of Pharmaceutical Education and Research-Ahmedabad
Design, synthesis and in-vitro evaluation of fluorinated triazoles as multi-target directed ligands for Alzheimer disease.
National Institute of Pharmaceutical Education and Research (NIPER)
Discovery of BMS-986251: A Clinically Viable, Potent, and Selective RORγt Inverse Agonist.
Bristol Myers Squibb
Use of a Conformational-Switching Mechanism to Modulate Exposed Polarity: Discovery of CCR2 Antagonist BMS-741672.
Bristol-Myers Squibb
Design, synthesis and biological evaluation of α-substituted isonipecotic acid benzothiazole analogues as potent bacterial type II topoisomerase inhibitors.
Biota Holdings
Rotenoids from Boerhaavia diffusa as potential anti-inflammatory agents.
National Institute of Pharmaceutical Education and Research (NIPER)